Differentiation potential of o bombay human-Induced pluripotent stem cells and human embryonic stem cells into fetal erythroid-like cells

Cell Journal

Volumn 16, Issue 4, 2015, Pages 426-439

  Ganji, Fatemeh ^a   Abroun, Saeid ^a,b   Baharvand, Hossein ^a   Aghdami, Nasser ^a   Ebrahimi, Marzieh ^a  

^a ROYAN INSTITUTE FOR REPRODUCTIVE BIOMEDICINE   (Iran)

^b TARBIAT MODARES UNIVERSITY   (Iran)

Author keywords

Differentiation; Erythroid cells; Hemangioblasts; Induced pluripotent stem cells

Indexed keywords

CD34 ANTIGEN; ERYTHROPOIETIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; GLYCOPHORIN A; HEMOGLOBIN; HEMOGLOBIN BETA CHAIN; HEMOGLOBIN F; INTERLEUKIN 3; INTERLEUKIN 6; SOMATOMEDIN C; STEM CELL FACTOR; TRANSCRIPTION FACTOR RUNX1; TRANSCRIPTION FACTOR TAL1; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ARTICLE; BLOOD GROUP ABO SYSTEM; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYO; EMBRYONIC STEM CELL; ENDOTHELIUM CELL; ERYTHROBLAST; ERYTHROID CELL; ERYTHROID PRECURSOR CELL; ERYTHROPOIESIS; FETUS; HEMANGIOBLAST; HEMATOPOIESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; PLURIPOTENT STEM CELL;

EID: 84920973801     PISSN: 22285806     EISSN: 22285814     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Liu QP, Yuan H, Bennett EP, Levery SB, Nudelman E, Spence J, et al. Identification of a GH110 subfamily of alpha 1,3-galactosidases: Novel enzymes for removal of the alpha 3Gal xenotransplantation antigen. J Biol Chem. 2008; 283(13): 8545-8554
2. Douay L, Andreu G. Ex vivo production of human red blood cells from hematopoietic stem cells: What is the future in transfusion?. Transfus Med Rev. 2007; 21(2): 91-100
3. Chang KH, Nelson AM, Cao H, Wang L, Nakamoto B, Ware CB, et al. Definitive-like erythroid cells derived from human embryonic stem cells coexpress high levels of embryonic and fetal globins with little or no adult globin. Blood. 2006; 108(5): 1515-1523
4. Park IH, Zhao R, West JA, Yabuuchi A, Huo H, Ince TA, et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature. 2008; 451(7175): 141-146
5. Boland MJ, Hazen JL, Nazor KL, Rodriguez AR, Gifford W, Martin G, et al. Adult mice generated from induced pluripotent stem cells. Nature. 2009; 461(7260): 91-94
6. Lengner CJ. iPS cell technology in regenerative medicine. Ann N Y Acad Sci. 2010; 1192: 38-44
7. Choi KD, Yu J, Smuga-Otto K, Salvagiotto G, Rehrauer W, Vodyanik M, et al. Hematopoietic and endothelial differentiation of human induced pluripotent stem cells. Stem Cells. 2009; 27(3): 559-567
8. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007; 318(5858): 1917-1920
9. Seifinejad A, Taei A, Totonchi M, Vazirinasab H, Hassani SN, Aghdami N, et al. Generation of human induced pluripotent stem cells from a Bombay individual: Moving towards "universal-donor" red blood cells. Biochem Biophys Res Commun. 2010; 391(1): 329-334
10. Baharvand H, Ashtiani SK, Taee A, Massumi M, Valojerdi MR, Yazdi PE, et al. Generation of new human embryonic stem cell lines with diploid and triploid karyotypes. Dev Growth Differ. 2006; 48(2): 117-128
11. Larijani MR, Seifinejad A, Pournasr B, Hajihoseini V, Hassani SN, Totonchi M, et al. Long-term maintenance of undifferentiated human embryonic and induced pluripotent stem cells in suspension. Stem Cells Dev. 2011; 20(11): 1911-1923
12. Kennedy M, DSouza SL, Lynch-Kattman M, Schwantz S, Keller G. Development of the hemangioblast defines the onset of hematopoiesis in human ES cell differentiation cultures. Blood. 2007; 109(7): 2679-2687
13. Fehling HJ, Lacaud G, Kubo A, Kennedy M, Robertson S, Keller G, et al.Tracking mesoderm induction and its specification to the hemangioblast during embryonic stem cell differentiation. Development. 2003; 130(17): 4217-4227
14. Kabrun N, Buhring HJ, Choi K, Ullrich A, Risau W, Keller G. Flk-1 expression defines a population of early embryonic hematopoietic precursors. Development. 1997; 124(10): 2039-2048
15. Mikkola HK, Fujiwara Y, Schlaeger TM, Traver D, Orkin SH. Expression of CD41 marks the initiation of definitive hematopoiesis in the mouse embryo. Blood. 2003; 101(2): 508-516
16. Yokochi T, Brice M, Rabinovitch PS, Papayannopoulou T, Stamatoyannopoulos G. Monoclonal antibodies detecting antigenic determinants with restricted expression on erythroid cells: From the erythroid committed progenitor level to the mature erythroblast. Blood. 1984; 63(6): 1376-1384
17. Krause DS, Fackler MJ, Civin CI, May WS. CD34: Structure, biology, and clinical utility. Blood. 1996; 87(1): 1-13
18. +cells: Efficient production in the coculture with OP9 stromal cells and analysis of lymphohematopoietic potential. Blood. 2005; 105(2): 617-626
19. Park C, Afrikanova I, Chung YS, Zhang WJ, Arentson E, Fong Gh Gh, et al. A hierarchical order of factors in the generation of FLK1- and SCL-expressing hematopoietic and endothelial progenitors from embryonic stem cells. Development. 2004; 131(11): 2749-2762
20. Yamaguchi TP, Dumont DJ, Conlon RA, Breitman ML, Rossant J. flk-1, an flt-related receptor tyrosine kinase is an early marker for endothelial cell precursors. Development. 1993; 118(2): 489-498
21. +erythroid progenitors: Temporal changes in gene and protein expression. Exp Hematol. 2003; 31(9): 760-769
22. Evans MJ, Kaufman MH. Establishment in culture of pluripotential cells from mouse embryos. Nature. 1981; 292(5819): 154-156
23. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, et al. Embryonic stem cell lines derived from human blastocysts. Science. 1998; 282(5391): 1145-1147
24. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007; 131(5): 861-872
25. Park IH, Arora N, Huo H, Maherali N, Ahfeldt T, Shimamura A, et al. Disease-specific induced pluripotent stem cells. Cell. 2008; 134(5): 877-886
26. Ma F, Ebihara Y, Umeda K, Sakai H, Hanada S, Zhang H, et al. Generation of functional erythrocytes from human embryonic stem cell-derived definitive hematopoiesis. Proc Natl Acad Sci USA. 2008; 105(35): 13087-13092
27. Lapillonne H, Kobari L, Mazurier C, Tropel P, Giarratana MC, Zanella-Cleon I, et al. Red blood cell generation from human induced pluripotent stem cells: perspectives for transfusion medicine. Haematologica. 2010; 95(10): 1651-1659
28. Lu SJ, Feng Q, Park JS, Vida L, Lee BS, Strausbauch M, et al. Biologic properties and enucleation of red blood cells from human embryonic stem cells. Blood. 2008; 112(12): 4475-4484
29. Honig GR, Lu SJ, Feng Q, Vida LN, Lee BS, Lanza R. alpha-Thalassemia-like globin gene expression by primitive erythrocytes derived from human embryonic stem cells. Hemoglobin. 2010; 34(2): 145-150
30. Chang CJ, Mitra K, Koya M, Velho M, Desprat R, Lenz J, et al. Production of embryonic and fetal-like red blood cells from human induced pluripotent stem cells. PLoS One. 2011; 6(10): e25761
31. Koda Y, Soejima M, Johnson PH, Smart E, Kimura H. Missense mutation of FUT1 and deletion of FUT2 are responsible for Indian Bombay phenotype of ABO blood group system. Biochem Biophys Res Commun. 1997; 238(1): 21-25
32. Koda Y, Soejima M, Wang B, Kimura H. Structure and expression of the gene encoding secretor-type galactoside 2-Alpha-L-fucosyltransferase (FUT2). Eur J Biochem. 1997; 246(3): 750-755
33. Tian X, Morris JK, Linehan JL, Kaufman DS. Cytokine requirements differ for stroma and embryoid body-mediated hematopoiesis from human embryonic stem cells. Exp Hematol. 2004; 32(10): 1000-1009
34. Okuda Y, Sakoda S, Fujimura H, Yanagihara T. Pentoxifylline delays the onset of experimental allergic encephalomyelitis in mice by modulating cytokine production in peripheral blood mononuclear cells. Immunopharmacology. 1996; 35(2): 141-148
35. Tavian M, Peault B. Embryonic development of the human hematopoietic system. Int J Dev Biol. 2005; 49(2-3): 243-250
36. Zambidis ET, Peault B, Park TS, Bunz F, Civin CI. Hematopoietic differentiation of human embryonic stem cells progresses through sequential hematoendothelial, primitive, and definitive stages resembling human yolk sac development. Blood. 2005; 106(3): 860-870
37. Pearson S, Sroczynska P, Lacaud G, Kouskoff V. The stepwise specification of embryonic stem cells to hematopoietic fate is driven by sequential exposure to Bmp4, activin A, bFGF and VEGF. Development. 2008; 135(8): 1525-1535
38. Wang L, Li L, Shojaei F, Levac K, Cerdan C, Menendez P, et al. Endothelial and hematopoietic cell fate of human embryonic stem cells originates from primitive endothelium with hemangioblastic properties. Immunity. 2004; 21(1): 31-41
39. Haar JL, Ackerman GA. A phase and electron microscopic study of vasculogenesis and erythropoiesis in the yolk sac of the mouse. Anat Rec. 1971; 170(2): 199-223
40. Palis J, McGrath KE, Kingsley PD. Initiation of hematopoiesis and vasculogenesis in murine yolk sac explants. Blood. 1995; 86(1): 156-163
41. Keller G. Embryonic stem cell differentiation: Emergence of a new era in biology and medicine. Genes Dev. 2005; 19(10): 1129-1155
42. Choi K, Kennedy M, Kazarov A, Papadimitriou JC, Keller G. A common precursor for hematopoietic and endothelial cells. Development. 1998; 125(4): 725-732
43. Park TS, Zimmerlin L, Zambidis ET. Efficient and simultaneous generation of hematopoietic and vascular progenitors from human induced pluripotent stem cells. Cytometry A. 2013; 83(1): 114-126
44. Peters A, Burridge PW, Pryzhkova MV, Levine MA, Park TS, Roxbury C, et al. Challenges and strategies for generating therapeutic patient-specific hemangioblasts and hematopoietic stem cells from human pluripotent stem cells. Int J Dev Biol. 2010; 54(6-7): 965-990
45. Palis J, Robertson S, Kennedy M, Wall C, Keller G. Development of erythroid and myeloid progenitors in the yolk sac and embryo proper of the mouse. Development. 1999; 126(22): 5073-5084
46. Sripichai O, Kiefer CM, Bhanu NV, Tanno T, Noh SJ, Goh SH, et al. Cytokine-mediated increases in fetal hemoglobin are associated with globin gene histone modification and transcription factor reprogramming. Blood. 2009; 114(11): 2299-2306
47. Wojda U, Leigh KR, Njoroge JM, Jackson KA, Natarajan B, Stitely M, et al. Fetal hemoglobin modulation during human erythropoiesis: Stem cell factor has "late" effects related to the expression pattern of CD117. Blood. 2003; 101(2): 492-497
48. Gabbianelli M, Testa U, Massa A, Morsilli O, Saulle E, Sposi NM, et al. HbF reactivation in sibling BFU-E colonies: Synergistic interaction of kit ligand with low-dose dexamethasone. Blood. 2003; 101(7): 2826-2832
49. Endo T, Odb A, Satoh I, Haseyama Y, Nishio M, Koizumi K, et al. Stem cell factor protects c-kit+ human primary erythroid cells from apoptosis. Exp Hematol. 2001; 29(7): 833-841
50. Zeuner A, Pedini F, Signore M, Testa U, Pelosi E, Peschle C, et al. Stem cell factor protects erythroid precursor cells from chemotherapeutic agents via up-regulation of BCL-2 family proteins. Blood. 2003; 102(1): 87-93.